Ms. Eun-Ah Paek, Executive Director at Boryung Co., Ltd., majored in Pharmacy at Sookmyung Women’s University, where she also earned her Master’s degree in Pharmacology. She subsequently completed her doctoral coursework in Pharmacoepidemiology at Sungkyunkwan University.
She previously served as a project leader for central nervous system (CNS) drug development at SK Biopharm and is currently in charge of clinical trials, post-marketing clinical research, pharmacovigilance, and medical writing as the head of the Clinical Division at Boryung.
With over 30 years of experience, she has been involved in comprehensive drug development, spanning from non-clinical research to clinical trials and post-marketing activities for pharmaceuticals.
Education: Department of Business, Tourism and Accounting, Major in Business Administration, Kangwon National University
Career: Daewon Pharmaceutical Co Ltd (Medical Representative – Distribution Manager – Sales Planner – Big Data Specialist)
Experienced clinical development leader with a proven record in strategic decision-making and cross-functional team leadership within global pharmaceutical organizations.
Expertise spans immunology, oncology, and allergy therapeutic areas, with deep experience in cross-border regulatory engagement and clinical trial execution.
Combines scientific rigor with a business-focused mindset, currently pursuing a PhD in health economics to further strengthen academic and strategic capabilities.
Benjamin Sanders is Senior Vice President of Strategy and Emerging Products at Lantern Specialty Care, where he leads corporate strategy, analytics, and the development of new service lines. Previously, Ben was at McKinsey & Company, advising Fortune 100 companies on large-scale transformations, digital strategy, and operational turnarounds. He began his career in political strategy, shaping messaging for national and international campaigns. Ben holds an MBA in Finance from Northwestern University’s Kellogg School of Management and a B.S. in Social Policy from Northwestern.
Zainab is a seasoned analytics expert with over 15 years of experience in Truven solutions, specializing in reporting, strategy, and healthcare analytics. She leads analysis on cost, utilization, and quality to inform business decisions, working closely with clients on measurement strategy, financial analysis, population health, and value-based care.
Jim is a Healthcare Executive with more than 25 years of experience in Leadership, Strategy, Data and Analytics, and Product Management. His current focus is on Product Strategy for MarketScan working closely with consultants, providers, health plans, employers, and healthcare technology companies to identify data, analytics, and benchmarking opportunities leveraging Truven’s real-world data assets.
Stephanie has nearly 3 decades of experience in the global biopharmaceutical industry specializing in end-to-end clinical development operations and delivery, strategic planning, and client management. She leads the team of biotech portfolio leaders focused on delivery excellence, functional connectivity, and customer partnership – ensuring programs move with the speed, flexibility and expertise biotech clients require. Stephanie’s core focus is to strengthen and evolve Fortrea’s biotech delivery strategy to stay ahead of industry needs, deliver with optimal agility and operational excellence, and consistently enhance the experience for our customers and their programs. She is passionate about cultivating strong, collaborative relationships – both within teams and with customers – and about equipping organizations to think entrepreneurially, move decisively, and deliver with accountability. As a biotech-focused leader within Global Project Delivery, Stephanie offers executive-level engagement for biotech customers to support success and achieve business objectives.
